
Share
4th November 2016
11:06am GMT

“Current methods for prenatal diagnosis of such mutations are limited because they are invasive…and most cannot be performed early in pregnancy. Down syndrome and other aneuploidies (abnormal number of chromosomes in a cell) occur in more than 0.2% of births worldwide and are on the rise because of advanced reproductive age.”The researchers are optimistic about the potential of the new method:
"This non-invasive platform has the potential to provide comprehensive foetal genomic profiling as early as five weeks of gestation"Due to the small number of women who were tested in the study, the findings are being welcomed but treated cautiously by medical professionals. Would you avail of this test if it became widely available to expectant mamas? Let us know in the comments or tweet us at @Herfamilydotie
Explore more on these topics: